Management of Esophageal Spasm Symptoms

First-Line Therapy

The American Gastroenterological Association recommends lifestyle optimization and weight management as initial management for patients with esophageal spasm symptoms 1
Proton pump inhibitors (PPIs) are the first-line pharmacologic treatment, as they are more effective than histamine-2 receptor antagonists (H2RAs), which are more effective than placebo 3
PPI optimization includes ensuring adequate timing of dose, considering escalation to twice daily dosing, or switching to a different PPI if symptoms persist, as suggested by the American College of Gastroenterology 2
When symptoms are adequately controlled, acid suppression should be weaned to the lowest effective dose or switched to H2RAs or other antacids, according to the American Gastroenterological Association 4

Adjunctive therapy should be tailored to the specific symptom phenotype rather than used empirically, as recommended by the American College of Gastroenterology 5
Alginate antacids are useful for breakthrough symptoms, particularly post-prandial and nighttime symptoms, and in patients with hiatal hernia, as suggested by the American Gastroenterological Association 6
H2RAs may help with breakthrough and nighttime symptoms, though their effectiveness is limited by tachyphylaxis, according to the American College of Gastroenterology 7
Baclofen (a GABA-B agonist) may be effective for belch-predominant symptoms and mild regurgitation, though often limited by CNS and GI side effects, as reported by the American Gastroenterological Association 8

For patients with persistent symptoms despite lifestyle and PPI optimization, neuromodulation with low-dose antidepressants should be considered, as recommended by the American College of Gastroenterology 7
Behavioral interventions including cognitive behavioral therapy (CBT), esophageal-directed hypnotherapy, and diaphragmatic breathing are beneficial for patients with esophageal hypervigilance, hypersensitivity, or behavioral disorders, according to the American Gastroenterological Association 7

If symptoms remain inadequately controlled despite optimization of therapy, additional testing should be performed, as suggested by the American College of Gastroenterology 4
High-resolution manometry should be used to assess esophageal peristaltic function and exclude achalasia, according to the American Gastroenterological Association 4
Gastric emptying testing may be indicated if delayed gastric emptying is suspected, as recommended by the American College of Gastroenterology 4
Ambulatory 24-hour pH-impedance monitoring on PPI therapy can help determine the mechanism of persisting symptoms and exclude other etiologies, as reported by the American Gastroenterological Association 8

For severely refractory cases, surgical interventions such as laparoscopic fundoplication may be considered, as suggested by the American College of Gastroenterology 5
Type of fundoplication can be tailored, with partial fundoplication preferred in patients with esophageal hypomotility, according to the American Gastroenterological Association 5

Metoclopramide is not recommended as monotherapy or adjunctive therapy for esophageal GERD syndromes, as stated by the American Gastroenterological Association 3
Prokinetics have not been shown to be useful in GERD but may have a role in patients with concomitant gastroparesis, according to the American College of Gastroenterology 8
Esophageal hypervigilance and visceral hypersensitivity can augment symptom burden and should be addressed with appropriate neuromodulation or behavioral interventions, as recommended by the American Gastroenterological Association 7
Sleeve gastrectomy has potential to worsen GERD symptoms and should be avoided in patients with proven GERD, as reported by the American College of Gastroenterology 9